Equifax (EFX) Stock Forecast & Price Target

$290.39

-0.23 (-0.08%)

(As of 09/27/2024 ET)

Equifax - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy

Based on 19 Analyst Ratings

Sell
0

Hold
4

Buy
15

Based on 19 Wall Street analysts who have issued ratings for Equifax in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 19 analysts, 4 have given a hold rating, 14 have given a buy rating, and 1 has given a strong buy rating for EFX.

Consensus Price Target

$302.06
4.02% Upside

According to the 19 analysts' twelve-month price targets for Equifax, the average price target is $302.06. The highest price target for EFX is $380.00, while the lowest price target for EFX is $267.00. The average price target represents a forecasted upside of 4.02% from the current price of $290.39.

Get the Latest News and Ratings for EFX and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Equifax and its competitors.

EFX Analyst Ratings Over Time

Type	Current Forecast 9/30/23 to 9/29/24	1 Month Ago 8/31/23 to 8/30/24	3 Months Ago 7/2/23 to 7/1/24	1 Year Ago 9/30/22 to 9/30/23
Strong Buy	1 Strong Buy rating(s)	1 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	14 Buy rating(s)	13 Buy rating(s)	14 Buy rating(s)	7 Buy rating(s)
Hold	4 Hold rating(s)	3 Hold rating(s)	3 Hold rating(s)	6 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	2 Sell rating(s)
Consensus Price Target	$302.06	$292.00	$270.19	$220.63
Forecasted Upside	4.02% Upside	-4.93% Downside	14.27% Upside	20.44% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Hold

Ex-Wall Street CEO reveals “Millionaire-Maker” Superdrug (Ad)

Science Magazine called it the "breakthrough of the year"... With projections of 8,966% growth in the next four years.

Click here for our #1 "Retirement Window" Stock >>>

EFX Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

EFX Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Equifax Stock vs. The Competition

Type	Equifax	Business Services Companies	S&P 500
Consensus Rating Score	2.84	2.66	2.50
Consensus Rating	Moderate Buy	Moderate Buy	Hold
Predicted Upside	4.02% Upside	303.06% Upside	6.16% Upside
News Sentiment Rating	Positive News See Recent EFX News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
9/19/2024	BNP Paribas 3 of 5 stars	A. Grobler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Underperform ➝ Neutral	$310.00	+4.18%
9/13/2024	Barclays 3 of 5 stars		Boost Target	Overweight ➝ Overweight	$300.00 ➝ $380.00	+24.12%
9/12/2024	Morgan Stanley 3 of 5 stars		Boost Target	Equal Weight ➝ Equal Weight	$250.00 ➝ $271.00	-9.05%
8/20/2024	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Neutral ➝ Neutral	$277.00 ➝ $307.00	+4.23%
8/13/2024	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Haas Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
7/24/2024	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$263.00 ➝ $304.00	+15.32%
Get the Latest News and Ratings for EFX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Equifax and its competitors with MarketBeat's FREE daily newsletter.
7/19/2024	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$273.00 ➝ $300.00	+12.94%
7/19/2024	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$265.00 ➝ $305.00	+15.45%
7/19/2024	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$272.00 ➝ $300.00	+13.55%
7/19/2024	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$305.00 ➝ $320.00	+21.12%
7/19/2024	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$260.00 ➝ $290.00	+9.77%
7/18/2024	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$255.00 ➝ $286.00	+10.34%
7/9/2024	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	S. Wurtzel Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Outperform	$275.00	+13.97%
2/13/2024	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	In-Line ➝ Outperform	$210.00 ➝ $310.00	+21.21%
2/9/2024	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$270.00 ➝ $285.00	+14.38%
1/11/2024	Redburn Atlantic Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Buy ➝ Neutral	$272.00	+11.10%
12/18/2023	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Hold ➝ Buy	$200.00 ➝ $315.00	+28.78%
12/8/2023	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Hold ➝ Buy	$218.00 ➝ $267.00	+19.05%
11/17/2023	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Outperform ➝ Outperform
7/21/2023	Credit Suisse Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform	$235.00 ➝ $250.00	+15.54%
11/15/2022	Atlantic Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Neutral ➝ Overweight	$230.00	+16.21%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 09:31 PM ET.

Should I Buy Equifax Stock? EFX Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Tuesday, September 10, 2024. Please send any questions or comments about these Equifax pros and cons to contact@marketbeat.com.

Equifax
Bull Case

Here are some ways that investors could benefit from investing in Equifax Inc.:

Equifax Inc. has consistently beaten analysts' earnings per share estimates, indicating strong financial performance.
The company has a healthy return on equity of 18.88%, showcasing efficient use of shareholder funds to generate profits.
Equifax Inc. has a dividend yield of 0.53%, providing investors with a steady income stream.
Several equity research analysts have given Equifax Inc. positive ratings and raised price targets, indicating confidence in the company's future growth potential.
The stock price of Equifax Inc. has shown a positive trend, with a 1-year high of $298.58, suggesting potential for capital appreciation.

Equifax
Bear Case

Investors should be bearish about investing in Equifax Inc. for these reasons:

Equifax Inc. has a relatively high price-to-earnings ratio of 65.09, which may indicate that the stock is currently overvalued compared to its earnings.
The company's debt-to-equity ratio of 1.01 suggests a significant reliance on debt financing, which can pose risks during economic downturns.
Insider selling activity, such as EVP Carla Chaney selling 3,000 shares, may raise concerns about insiders' confidence in the company's future performance.
Equifax Inc.'s dividend payout ratio of 34.74% indicates that a significant portion of earnings is being distributed as dividends, potentially limiting reinvestment for growth.
The company's beta of 1.56 implies higher volatility compared to the market, which may lead to fluctuations in the stock price.

EFX Forecast - Frequently Asked Questions

: According to the research reports of 19 Wall Street equities research analysts, the average twelve-month stock price forecast for Equifax is $302.06, with a high forecast of $380.00 and a low forecast of $267.00.
: 19 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Equifax in the last twelve months. There are currently 4 hold ratings, 14 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" EFX shares.
: According to analysts, Equifax's stock has a predicted upside of 4.02% based on their 12-month stock forecasts.
: Over the previous 90 days, Equifax's stock had 2 upgrades by analysts.
: Equifax has been rated by research analysts at Bank of America, Barclays, BNP Paribas, Citigroup, JPMorgan Chase & Co., Morgan Stanley, Needham & Company LLC, Oppenheimer, Robert W. Baird, Stifel Nicolaus, The Goldman Sachs Group, Wells Fargo & Company, and Wolfe Research in the past 90 days.
: Analysts like Equifax more than other "business services" companies. The consensus rating score for Equifax is 2.84 while the average consensus rating score for "business services" companies is 2.66. Learn more on how EFX compares to other companies.

Stock Forecasts and Research Tools

Related Companies:

Today's Ratings:

Top Rated Stocks:

More Ratings Tools:

Massive NVIDIA Sell-Off: Are We Headed for a Market Collapse? (Ad)

You may have heard about NVIDIA's CEO dumping shares of his own company. He sold 4.4 million shares this year. But here's what's even more concerning...

Click here for his urgent warning - and 4 steps you need to take today to protect your retirement to

This page (NYSE:EFX) was last updated on 9/29/2024 by MarketBeat.com Staff

From Our Partners